Insights on the Gout Therapeutics Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global gout therapeutics market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor contributing to the growth of the market include the increasing prevalence of gout across the globe. According to the National Center for Biotechnology Information (NCBI), an estimated 1 to 2% of the population is affected by gout globally. Additionally, men are more likely to get it than women with an estimated five times more in men. Furthermore, gout mostly occurs in men aged 40 and above while it usually only affects women after menopause. Hence, the increasing prevalence of gout is driving the demand for gout treatment, which in turn is driving the growth of the market.
Moreover, the market is segmented
into drug class and application. Based on drug class, the market is
sub-segmented into antihyperuricemic agents (Urate-Lowering Drugs),
non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, colchicine and
others. Based on application, the market is sub-segmented into acute gout and
chronic gout. NSAIDs hold a prominent share in the market due to their low cost
compared to other pharmacological classes coupled with their ability to relieve
pain in the case of a severe attack.
To Request a Sample of our Report on Gout Therapeutics
Market: https://www.omrglobal.com/request-sample/gout-therapeutics-market
Some major key players in the market include Pfizer Inc.,
Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd., among
others. The market players are contributing significantly to the growth of the
market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in April
2021, HemoShear Therapeutics, Inc. has collaborated with Horizon Therapeutics
plc to identify a second drug for the treatment of gout.
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
·
By Drug Class
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries
Ltd., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Gout Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/gout-therapeutics-market
Global Gout Therapeutics Market Report by Segment
By Drug Class
• Antihyperuricemic Agents (Urate-Lowering
Drugs)
• Non-steroidal Anti-inflammatory Drugs
(NSAIDs)
• Corticosteroids
• Colchicine
• Others
By Application
• Acute Gout
• Chronic Gout
Global Gout Therapeutics Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment